2015 Q1 Form 10-Q Financial Statement

#000146310115000023 Filed on May 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $86.65M $57.58M
YoY Change 50.49% 26.34%
Cost Of Revenue $58.63M $38.93M
YoY Change 50.62% 16.63%
Gross Profit $28.02M $18.66M
YoY Change 50.22% 52.9%
Gross Profit Margin 32.34% 32.4%
Selling, General & Admin $20.14M $15.35M
YoY Change 31.18% 19.15%
% of Gross Profit 71.87% 82.31%
Research & Development $13.43M $9.086M
YoY Change 47.81% 0.66%
% of Gross Profit 47.92% 48.71%
Depreciation & Amortization $2.532M $1.910M
YoY Change 32.57% 15.06%
% of Gross Profit 9.04% 10.24%
Operating Expenses $33.57M $24.44M
YoY Change 37.36% 11.54%
Operating Profit -$5.548M -$5.785M
YoY Change -4.1% -40.43%
Interest Expense $78.00K $449.0K
YoY Change -82.63% -3.23%
% of Operating Profit
Other Income/Expense, Net -$605.0K -$342.0K
YoY Change 76.9% -33.33%
Pretax Income -$6.153M -$6.127M
YoY Change 0.42% -40.07%
Income Tax $167.0K $109.0K
% Of Pretax Income
Net Earnings -$6.320M -$6.236M
YoY Change 1.35% -40.07%
Net Earnings / Revenue -7.29% -10.83%
Basic Earnings Per Share
Diluted Earnings Per Share -$143.2K -$146.9K
COMMON SHARES
Basic Shares Outstanding 43.95M shares 42.24M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.10M $39.90M
YoY Change -32.08% 9.62%
Cash & Equivalents $27.13M $39.94M
Short-Term Investments
Other Short-Term Assets $7.100M $4.300M
YoY Change 65.12% 72.0%
Inventory $34.75M $14.11M
Prepaid Expenses
Receivables $45.87M $28.45M
Other Receivables $0.00 $0.00
Total Short-Term Assets $114.8M $86.78M
YoY Change 32.32% 0.74%
LONG-TERM ASSETS
Property, Plant & Equipment $31.20M $24.81M
YoY Change 25.75% -1.87%
Goodwill $3.745M
YoY Change
Intangibles $1.704M
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.014M $1.570M
YoY Change 28.28% -4.33%
Total Long-Term Assets $38.66M $26.38M
YoY Change 46.56% -2.02%
TOTAL ASSETS
Total Short-Term Assets $114.8M $86.78M
Total Long-Term Assets $38.66M $26.38M
Total Assets $153.5M $113.2M
YoY Change 35.64% 0.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.95M $9.353M
YoY Change 230.95% 3.27%
Accrued Expenses $20.23M $13.58M
YoY Change 48.99% -26.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.370M
YoY Change 38.11%
Total Short-Term Liabilities $62.29M $34.10M
YoY Change 82.7% 9.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $4.457M
YoY Change -100.0% -44.61%
Other Long-Term Liabilities $2.387M $1.272M
YoY Change 87.66% 261.36%
Total Long-Term Liabilities $2.387M $5.729M
YoY Change -58.33% -31.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $62.29M $34.10M
Total Long-Term Liabilities $2.387M $5.729M
Total Liabilities $109.5M $76.72M
YoY Change 42.73% 18.11%
SHAREHOLDERS EQUITY
Retained Earnings -$167.3M -$159.2M
YoY Change 5.11% 15.82%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.98M $36.44M
YoY Change
Total Liabilities & Shareholders Equity $153.5M $113.2M
YoY Change 35.64% 0.08%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$6.320M -$6.236M
YoY Change 1.35% -40.07%
Depreciation, Depletion And Amortization $2.532M $1.910M
YoY Change 32.57% 15.06%
Cash From Operating Activities -$11.50M $4.281M
YoY Change -368.58% -161.4%
INVESTING ACTIVITIES
Capital Expenditures $3.611M $2.172M
YoY Change 66.25% 29.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$3.611M -$2.172M
YoY Change 66.25% 29.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $866.0K
YoY Change -100.0% 46.53%
Cash From Financing Activities $677.0K -$412.0K
YoY Change -264.32% 1371.43%
NET CHANGE
Cash From Operating Activities -$11.50M $4.281M
Cash From Investing Activities -$3.611M -$2.172M
Cash From Financing Activities $677.0K -$412.0K
Net Change In Cash -$14.43M $1.697M
YoY Change -950.44% -119.55%
FREE CASH FLOW
Cash From Operating Activities -$11.50M $4.281M
Capital Expenditures $3.611M $2.172M
Free Cash Flow -$15.11M $2.109M
YoY Change -816.41% -124.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001463101
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44155790 shares
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q1 enph Product Warranty Accrual Current Fair Value Disclosure
ProductWarrantyAccrualCurrentFairValueDisclosure
1534000 USD
CY2014Q4 enph Product Warranty Accrual Noncurrent Fair Value Disclosure
ProductWarrantyAccrualNoncurrentFairValueDisclosure
2437000 USD
CY2015Q1 enph Product Warranty Accrual Noncurrent Fair Value Disclosure
ProductWarrantyAccrualNoncurrentFairValueDisclosure
3249000 USD
CY2014Q1 enph Product Warranty Accrual Other
ProductWarrantyAccrualOther
-4000 USD
CY2015Q1 enph Product Warranty Accrual Other
ProductWarrantyAccrualOther
50000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22316000 USD
CY2014Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
102000 USD
CY2015Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
39000 USD
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9514000 shares
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
Enphase Energy, Inc.
CY2015Q1 enph Business Combination Contingent Consideration Arrangements Determination Period
BusinessCombinationContingentConsiderationArrangementsDeterminationPeriod
P2Y
CY2014Q1 enph Increase Decreasein Product Warranty Accrual
IncreaseDecreaseinProductWarrantyAccrual
296000 USD
CY2015Q1 enph Increase Decreasein Product Warranty Accrual
IncreaseDecreaseinProductWarrantyAccrual
223000 USD
CY2014Q1 enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
20000 USD
CY2015Q1 enph Product Warranty Accrual Accretion Expense
ProductWarrantyAccrualAccretionExpense
161000 USD
CY2014Q4 enph Product Warranty Accrual Current Fair Value Disclosure
ProductWarrantyAccrualCurrentFairValueDisclosure
1125000 USD
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
30954000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45119000 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45870000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26036000 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20230000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-79000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-395000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
208022000 USD
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
211687000 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2013000 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2988000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
569000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
533000 USD
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10171000 shares
CY2014Q4 us-gaap Assets
Assets
152192000 USD
CY2015Q1 us-gaap Assets
Assets
153490000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
114896000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
114830000 USD
CY2014Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2015Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
104000 USD
CY2014Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
497000 USD
CY2015Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1269000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38190000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39935000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42032000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27127000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1745000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14905000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43756000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44117000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43756000 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44117000 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6235000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6636000 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
38925000 USD
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
58629000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2747000 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3558000 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
16612000 USD
CY2015Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
18217000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1910000 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2532000 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
48000 USD
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-473000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
24400000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M6D
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
125000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
232000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
323000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
180000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
180000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
305000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
430000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1650000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1650000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1525000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1418000 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-6000 USD
CY2015Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-191000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6526000 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8205000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
3745000 USD
CY2015Q1 us-gaap Goodwill
Goodwill
3745000 USD
CY2014Q4 us-gaap Goodwill Gross
GoodwillGross
3745000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.15
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.14
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
167000 USD
CY2015Q1 us-gaap Goodwill Gross
GoodwillGross
3745000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
18655000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
28024000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5785000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5548000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6127000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6153000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1159000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2305000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3608000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
751000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-93000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2416000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2467000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13156000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
977000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2069000 USD
CY2014Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
286000 USD
CY2015Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
286000 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1811000 USD
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1704000 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
449000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
78000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18161000 USD
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
30567000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
21590000 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
34746000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3429000 USD
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
4179000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
105240000 USD
CY2015Q1 us-gaap Liabilities
Liabilities
109509000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152192000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
153490000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58706000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
62292000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-412000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
677000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2172000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3611000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4281000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11498000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2014000 USD
CY2014Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1000 USD
CY2015Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-316000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3589000 USD
CY2014Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
5894000 USD
CY2014Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
7607000 USD
CY2015Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
7550000 USD
CY2014Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
24834000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-6236000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-6320000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-342000 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-605000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
24440000 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
33572000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
916000 USD
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2387000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
107000 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-527000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2172000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3611000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6155000 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7087000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
454000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
677000 USD
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
30432000 USD
CY2014Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
30728000 USD
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
33940000 USD
CY2015Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
34163000 USD
CY2014Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
26333000 USD
CY2015Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
26613000 USD
CY2014Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1400000 USD
CY2015Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
58000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30824000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31197000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13430000 USD
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11937000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2013000 USD
CY2015Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1151000 USD
CY2014Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
613000 USD
CY2015Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1105000 USD
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
188000 shares
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
46952000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
43981000 USD
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
42205000 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43950000 shares
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
26000 USD
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2014Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
866000 USD
CY2015Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9086000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2988000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1800000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
45000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.83
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
197000 shares
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-160991000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-167311000 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
57580000 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
86653000 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8828000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
71700000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8632000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8596000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.75
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.92
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.65
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.17
CY2014Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1733000 USD
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant estimates and assumptions reflected in the financial statements include revenue recognition, inventory valuation and accrued warranty obligations. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ materially from management&#8217;s estimates using different assumptions or under different conditions.</font></div></div>

Files In Submission

Name View Source Status
0001463101-15-000023-index-headers.html Edgar Link pending
0001463101-15-000023-index.html Edgar Link pending
0001463101-15-000023.txt Edgar Link pending
0001463101-15-000023-xbrl.zip Edgar Link pending
doc116260539v3forctre_image1.gif Edgar Link pending
R42.htm Edgar Link pending
doc116260539v3forctre_image2.gif Edgar Link pending
enph-20150331.xml Edgar Link completed
enph-20150331.xsd Edgar Link pending
enph-20150331_cal.xml Edgar Link unprocessable
enph-20150331_def.xml Edgar Link unprocessable
enph-20150331_lab.xml Edgar Link unprocessable
enph-20150331_pre.xml Edgar Link unprocessable
enph0331201510-q.htm Edgar Link pending
enph03312015ex101.htm Edgar Link pending
enph03312015ex102.htm Edgar Link pending
enph03312015ex103.htm Edgar Link pending
enph03312015ex3101.htm Edgar Link pending
enph03312015ex3102.htm Edgar Link pending
enph03312015ex3201.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending